Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston to distribute CorTrak's products:

This article was originally published in Clinica

Executive Summary

Boston Scientific will exclusively distribute the coronary iontophoresis drug delivery products which are being developed by CorTrak Medical. Boston has also made an unspecified equity investment in CorTrak, which is based in Minneapolis. The CorTrak system is in pre-clinical studies and uses a catheter and an electric field to transport drugs through difficult tissue barriers and into cells. Initially, the company will focus on treating and preventing problems associated with coronary angioplasty.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089371

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel